Current Report Filing (8-k)
June 04 2020 - 4:22PM
Edgar (US Regulatory)
false 0001356090 --12-31 0001356090 2020-06-03 2020-06-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 3, 2020
Precigen, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
Virginia
|
|
001-36042
|
|
26-0084895
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
20374 Seneca Meadows Parkway, Germantown, Maryland 20876
(Address of principal executive offices) (Zip Code)
(301) 556-9900
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to 12(b) of the Act:
|
|
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
|
Common Stock, No Par Value
|
|
PGEN
|
|
Nasdaq Global Select Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 5.03
|
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
On June 3, 2020, the Board of Directors (the “Board”) of Precigen, Inc. (“Precigen”) amended and restated Precigen’s Amended and Restated Bylaws (the “Bylaws”) to expressly permit Precigen to hold shareholder meetings solely by means of remote communication as the Board may determine in its discretion. The Bylaws previously only permitted shareholder meetings to be held at a place. The amendments were made to Sections 1.1, 1.4 and 1.6 of the Bylaws. The foregoing description is qualified in its entirety by reference to the full text of the Bylaws, as amended and restated, which is filed herewith as Exhibit 3.1 and incorporated by reference herein.
|
Item 9.01
|
Financial Statements and Exhibits.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
Precigen, Inc.
|
|
|
|
|
|
By:
|
|
/s/ Donald P. Lehr
|
|
|
|
Donald P. Lehr
|
|
|
|
Chief Legal Officer
|
Dated: June 4, 2020
Intrexon (NASDAQ:XON)
Historical Stock Chart
From Apr 2024 to May 2024
Intrexon (NASDAQ:XON)
Historical Stock Chart
From May 2023 to May 2024
